Oncology Publications

Seagrove Partners’ Extensive Library of Market Reports and Tumor Primers

 

Seagrove Partners, a boutique healthcare market research company based in San Diego, has created an extensive library of oncology research reports that serve as detailed market primers for industry professionals, clinical researchers and students. The research is anchored by the annual Oncology Blue Book which provides an overview of the commercial landscape, clinical outcomes, company pipelines, and product messaging for 13 different tumor types (oncology and hematology). Following the Blue Book are extensive deep dives into areas like Breast Cancer, Lymphoma, Lung Cancer, Multiple Myeloma and Pancreatic Cancer. Seagrove also publishes primary market research findings from surveys with Oncology Nurses, Prescribers and Payers.

The 2022 Oncology Blue Book. Your One-Stop for Market Data, Facts, Figures and Insights.

Published annually after ASCO, the Oncology Blue Book provides detailed overviews of the following tumor types: Bladder Cancer, Breast Cancer, CRC, Leukemia, Liver Cancer, Lung Cancer, Lymphoma, Melanoma, Multiple Myeloma, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, and Renal Cancer. 350+ Pages.

The Oncology Forum:


SeaTRAK™ Quarterly Monitor

Seagrove’s quarterly market tracker published after earnings season. Includes updates to market statistics, company earnings coverage and analysis, and pipeline updates.

Other Oncology Publications

  • Breast Cancer Primer

    Market statistics, disease background, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles, companion diagnostics. 151 pages.

  • Lung Cancer Primer

    Market statistics, disease background, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles, companion diagnostics. 176 pages.

  • Colorectal Cancer Primer

    Market statistics, disease background, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles, companion diagnostics. 118 pages.

  • Pancreatic Cancer Primer

    Market statistics, disease background, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles.

    95 pages.

  • Checkpoint Inhibitors Primer

    Market statistics, CPI History and Science, Top 10 Oncology: Overview and I-O Pipelines, Biopharma: CPI Players, Outcomes Data.

    181 pages.

  • CAR T Market Primer

    Market statistics, history of CAR T, commercial market overview, clinical investigators, outcomes data, company profiles/pipelines, product profiles.

    99 pages.

  • ASH Conference Coverage

  • SITC Conference Coverage

  • ESMO Conference Coverage

  • 2021 Payer Perspectives

    Managed Care Market Primer, Coverage Processes, Cost Containment Programs, Formulary Tracker Questions, Reactions to New Therapies. 71 pages. 50 Plans.

  • 2021 Oncology Nurses Survey

    Practice Profiles, Industry Statistics, General Trends in Oncology Management, Breast Cancer, Hematology, General (Non-Tumor Specific). 78 pages. 230 Responses.

  • 2021 Oncology HCP Survey

    Practice Profiles, Industry Statistics, General Trends in Oncology Management, Breast Cancer, Hematology, General (Non-Tumor Specific) Ad-Hoc Tumor Questions 96 pages. 146 Responses.